Subscribe to RSS

DOI: 10.1055/s-0044-1790544
Understanding the Malignancy Potential of Cutaneous/Subcutaneous Lesions: Insight from 9,202 Day-Surgery Procedures
Authors
Abstract
Objectives
Cutaneous and subcutaneous lesions often go unnoticed or disregarded, yet they can harbor malignant potential. These seemingly innocuous bumps and lumps vary in size and nature, necessitating thorough evaluation by health care professionals. In this study encompassing 9,202 day-surgery procedures, we sought to elucidate the malignancy risk associated with cutaneous/subcutaneous lesions.
Materials and Methods
Conducted as a descriptive case-control investigation, our study enrolled patients undergoing excision for such lesions from 2009 to 2018. Patients were stratified into study (malignancy confirmed by histopathology) and control groups. Comprehensive data collection included demographic profiles, pathology reports, surgical details, and follow-up outcomes.
Results
Analysis of 9,202 excision procedures involving 8,962 patients revealed epidermal/tricholemmal cyst as the most prevalent lesion type (34.5%), followed by lipomas (21.8%). Malignancies were identified in 1.1% of cases, predominantly affecting older individuals (mean age: 60.3 ± 16.2 years). While malignancy incidence correlated with advancing age, no significant gender disparity was observed (p < 0.001 and p = 0.353, respectively).
Conclusion
Our findings underscore the imperative of vigilance toward cutaneous and subcutaneous lesions, as they may harbor malignancy. Timely assessment by health care providers is paramount to promptly identify and manage potentially malignant lesions. With malignancy detected in over 1% of cases, our study emphasizes the necessity for meticulous evaluation and appropriate intervention strategies to mitigate associated risks effectively.
Keywords
cutaneous lesion - subcutaneous lesion - excisional biopsy - minor surgery - malignancy potentialAuthors' Contribution
F.B., A.A., İ.K. contributed to the concept and design of the study; data acquisition; statistical analysis; F.B., A.A., H.T., Y.K.Ç. interpreted the results; analyzed the data and drafted the manuscript. All authors critically revised the manuscript, approved the final version to be published, and agree to be accountable for all aspects of the work.
Ethical Considerations
The study was performed according to the Helsinki Declaration, and institutional review board approval was obtained. All the patients and/or their patients/guardian signed a general consent form allowing anonymous use of data for education, research, and quality improvement. The authors confirm that data were collected retrospectively and anonymously in the medical institution according to personal data privacy rules. This study does not contain identifying information of the patients.
Ethical Approval
This study was approved by the Ethics Committee of the University of Health Sciences, Umraniye Education and Research Hospital (Approval Number/Date: B.10.1.TKH.4.34.H.GP.0.01/245/2024).
Reporting Guidelines
STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines were used when reporting this observational study.
Publication History
Received: 04 April 2024
Accepted: 26 July 2024
Article published online:
10 September 2024
© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Kwon EJ, Kwon JY. Malignancy potential of cutaneous and subcutaneous lesions: a retrospective study. J Dermatol 2019; 46 (03) 201-206
- 2 Pan J, Zhong C, Shao Z. et al. Outpatient surgery of skin and soft tissue lesions: case summary and perspectives on training. Clin Pract 2017; 14 (02) 111-116
- 3 Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg 2005; 9 (01) 10-15
- 4 Mandava A, Ravuri PR, Konathan R. High-resolution ultrasound imaging of cutaneous lesions. Indian J Radiol Imaging 2013; 23 (03) 269-277
- 5 Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26 (06) 976-990
- 6 Schmults CD, Blitzblau R, Aasi SZ. et al. Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2023; Nov; 21 (11) 1181-1203
- 7 American Cancer Society. Risks of cancer surgery. Accessed April 2, 2023 at: https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/surgery/risks-of-cancer-surgery.html
- 8 American Cancer Society. Skin cancer. 2021. Accessed April 2, 2023 at: https://www.cancer.org/cancer/skin-cancer.html
- 9 World Health Organization. Skin cancer - International Agency for Research on Cancer (IARC). Accessed August 20, 2024 at https://www.iarc.who.int/cancer-type/skin-cancer/
- 10 Al Barwani AS, Taif S, Al Mazrouai RA, Al Muzahmi KS, Alrawi A. Dermatofibrosarcoma protuberans: insights into a rare soft tissue tumor. J Clin Imaging Sci 2016; 6: 16
- 11 Katalinic A, Eisemann N, Waldmann A. Skin cancer screening in Germany. documenting melanoma incidence and mortality from 2008 to 2013. Dtsch Arztebl Int 2015; 112 (38) 629-634
- 12 Goulart JM, Quigley EA, Dusza SW, Halpern AC. Melanoma detection and outcomes among patients with skin lesions concerning for melanoma. JAMA Dermatol 2018; 154 (04) 445-451
